Clinical Trials Browser

Enrolling by invitation × INDUSTRY × Stomach Neoplasms × Clear all

NCT07218003 2026-05-04

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06391749 2025-07-16

K-ACCELERATE

Enrolling by invitation

1,000 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Liver Neoplasms, Lung Neoplasms, Stomach Neoplasms